Alterations in GDNF-RET signalling are associated with ALS pathology, with increased microglial RET immunoreactivity in SOD1G93A mice [22], and increased GDNF levels in ALS patient muscle biopsies [23]. This evidence concerns the gene GDNF and amyotrophic lateral sclerosis.